Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome
Recruiting
Phase 4
Interventional Study
Acute Respiratory Distress Syndrome (ARDS)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- National Taiwan University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The early phase of Acute Respiratory Distress Syndrome (ARDS) is characterized by intense alveolar inflammation. Corticosteroids have been used to treat ARDS for decades. Although their efficacy has been a subject of ongoing controversy, recent clinical practice guidelines for ARDS issued a weak recommendation in favor of corticosteroid use in early ARDS. However, the optimal dose and duration of …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ARDS (as defined by the Berlin definition) with an FiO₂ of 0.5 or higher
* On invasive mechanical ventilation
* Duration of intubation less than three days
Exclusion Criteria:
* Age less than 18 years
* Required to receive steroids or considered ineligible for steroids by th…
Contacts